Abstract:Introdution Kidney transplantation (KT) is the treatment of choice for patients with end-stage chronic kidney disease. After KT, the graft may not function immediately and the patient needs to undergo dialysis, characterizing delayed graft function (DGF). DGF increases length of hospital stay, costs and reduces graft survival. The incidence of DGF is higher in expanded criteria donor (ECD), prolonged cold ischemia time (CIT) and donors with renal dysfunction. There are two methods of renal preservation: the traditional, cold storage (CS) and machine perfusion (MP). MP is a high-cost technology, restricted to few hospitals and studies showed that it reduces the incidence of DGF. Objectives Analyze the incidence of DGF, its duration, CIT, length of hospital stay, graft and patient survival one year after transplantation and renal function estimated by the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation at 1, 3, 6, 9 and 12 months in patients transplanted with CS kidneys compared to MP after CS. Methods: This study was retrospective cohort, in a single center. We included transplants from DCE or standard deceased donors if CIT ≥ 24 hours, cardiorespiratory arrest before donation or creatinine ≥1.8mg&sol;dL prior to retrieval from January 2015 to December 2016 with 1 year follow up. Results Sample was 92 patients, 52 transplanted with kidneys in MP. Demographic characteristics were similar between groups except for age of recipient that was higher in the MP group, p=0.03 and donor creatinine prior to retrieval which was 0.7mg&sol;dL higher in the CS group, p=0.01. The incidence of DGF was 86.5&percnt; in the MP group and 95&percnt; in the CS group, p=0.29. There was no difference in DGF duration between groups. The MP patients remained 7 days less hospitalized than the patients in CS, p = 0.15. CIT was 8.19 hours higher in the MP group, p<0.01. CIT of kidneys in MP was 13.63 hours. Graft survival was 90.4&percnt; in the MP group and 87.5&percnt; in the CS patients, p = 0.69. Patient survival was 94.2&percnt; in the MP group and 95&percnt; in the PE group, p = 0.86. There were no differences in creatinine clearances at 1, 3, 6, 9 and 12 months. One year after transplantation, 89.6&percnt; of MP patients and 66.7&percnt; of CS group had creatinine clearance higher than 30mL&sol;min&sol;1.73m2, p=0.01. In the multivariate analysis, risk factors for worse graft function at 1 year were: donor age (OR 1.11 CI95&percnt; 1.01-1.22; p=0,03) and CS preservation (OR 6.52 CI 95&percnt; 1.46-29.08; p=0.01). Conclusions: The incidence of DGF was high and there were no statistical differences between the groups. The higher CIT in the MP group did not increase incidence of DGF. Patients in the MP group were hospitalized 7 days less than the CS group, although there was no statistical difference. Patient and graft survival were high one year after KT, no differences between groups. MP showed better graft function one year after KT. Table. No title available. Table. No title available. Figure. No caption available. Figure. No caption available.

Severe Early Graft Dysfunction Post-Heart Transplantation: Two Clinical Trajectories and Diastolic Perfusion Pressure as a Predictor of Mechanical Circulatory Support

Delayed graft function is correlated with graft loss in recipients of expanded-criteria rather than standard-criteria donor kidneys: a retrospective, multicenter, observation cohort study.

Association of Pulmonary Artery Pressure Change with Post-Lung Transplantation Survival: Retrospective Analysis of China Registry

Severe Primary Graft Dysfunction in Heart Transplant Recipients Using Donor Hearts After Circulatory Death: United States Experience

Recipient and surgical factors trigger severe primary graft dysfunction after heart transplant

Continuous-flow mechanical circulatory support is not associated with early graft failure: An analysis of the International Society for Heart and Lung Transplantation registry

Risk Factors for Severe Primary Graft Dysfunction in Infants Following Heart Transplant

Predictive Value of Intraoperative Doppler Flowmetry for Delayed Graft Function in Kidney Transplantation: A Pilot Study

Mechanical circulatory support early after pediatric heart transplantation-an analysis from the Pediatric Heart Transplant Society

Intraoperative Mean Arterial Pressure and Postoperative Delayed Graft Function in Kidney Transplantation: Evaluating Three Commonly Used Thresholds

Myocardial injury biomarkers at point of care for early identification of primary graft dysfunction after heart transplantation

Primary Graft Dysfunction Is Associated With Development of Early Cardiac Allograft Vasculopathy, but Not Other Immune-mediated Complications, After Heart Transplantation

Incidence and Predictors of Vasoplegia after Heart Transplantation: Results from the International PGD Consortium

Major determinants of primary non function from kidney donation after Maastricht II circulatory death: A single center experience

Early vs. Delayed Mechanical Circulatory Support in Patients with Acute Myocardial Infarction and Cardiogenic Shock

Necropsy findings in heart transplant recipients with or without primary graft dysfunction

Impact of Machine Perfusion on Delayed Graft Function and Graft Survival from High-Risk Donors

PREDICTA: A Model to Predict Primary Graft Dysfunction After Adult Heart Transplantation in the United Kingdom

Primary graft dysfunction in heart transplantation: the challenge to survival

Vasopressor selection during critical care management of brain dead organ donors and the effects on kidney graft function

Use of extracorporeal membrane oxygenation for heart graft dysfunction in adults: incidence, risk factors and outcomes in a multicentric study